The Defibrillator Market size was estimated at USD 7.07 billion in 2023 and is expected to reach USD 13.98 billion by 2031 at a CAGR of 8.71% during the forecast period of 2024-2031.
A defibrillator is a medical equipment that treats life-threatening conditions such ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia by shocking the patient's heart. It functions by delivering electric shockwaves or pulses to the heart to assist in reestablishing a regular heartbeat. Some of the most common types of defibrillators include automated external defibrillators (AEDs), manual/wearable external defibrillators, implantable cardioverter defibrillators (ICDs), and transvenous or subcutaneous implantable cardioverter defibrillators.
.png)
Get more information on Defibrillator Market - Request Free Sample Report
DRIVERS
Increasing prevalence of diseases
Rising global geriatric population
Cardiovascular conditions like coronary artery disease and cardiac arrest affect a significant section of the population worldwide. The rising fatalities around the world is caused by the rising prevalence of cardiovascular illnesses. In 2022, The Centers for Disease Control and Prevention (CDC) estimate that, CVD will be responsible for over 725,000 deaths in the US. Furthermore, arrhythmia-related sudden cardiac death is more likely as a result of coronary artery disease. In the US, there are reported to be over 356,000 out-of-hospital cardiac arrests (OHCA) each year, according to research from the Coronary Artery Disease Foundation from 2022.
RESTRAIN
Issues related to the usage of implantable and automated external defibrillators
Public access defibrillators (or automated external defibrillators) are often found to be associated with technical issues such as battery defects or hardware defects. Similar to this, issues with electronics, connectors, and wiring are regularly observed. These flaws frequently cause the gadget to fail to deliver an electric shock in a timely manner. Therefore, when making a purchase decision, emergency care professionals or public access facilities frequently like to adopt well-known brands with an established track record of product quality. Therefore, ICD and AED-related techno-commercial concerns constitute a significant global market restraint for growing vendors and local distributors.
OPPORTUNITY
Increasing number of mergers and acquisitions among market key players
The defibrillator market's major competitors are increasingly acquiring rival companies to diversify their product portfolios internationally. These acquisitions assist producers of implanted and external defibrillators in increasing their financial foundations, expanding into new areas, and providing patients with a wide selection of products. Despite the rising cost challenges, acquisitions help defibrillator manufacturers retain their profit margins and expand their presence around the world.
CHALLENGES
Lack of awareness about sudden cardiac arrests in developing nations
Defibrillators are required to follow strict regulatory guidelines and quality standards in order to deliver precise and accurate test results. It can be challenging for manufacturers to comply with changing legislation because it calls for ongoing improvements to practices, hardware, and software. The establishment and maintenance of a quality management system (QMS) is commonly required of defibrillator manufacturers to ensure compliance with legal standards. Part of this involves putting policies and procedures into place for the design, development, manufacture, installation, servicing, and post-market monitoring of the analyzers. To receive market approval for their Defibrillators, manufacturers must carefully navigate the regulatory environment and adhere to the relevant regulations.
Non-communicable diseases (NCDs) are the leading cause of morbidity and mortality inUkraine, with the five major NCDs (cardiovascular disease [CVD], diabetes, cancer, chronic respiratory disease, and mental health conditions) accounting for 84% of all mortality. Ukraine also has some of the highest burden of chronic infectious diseases in Europe, specifically in HIV and Tuberculosis (TB)/Multi-drug resistant (MDR)-TB. Shortages of medical supplies, challenging access to essential health services, and the interruption of prevention, diagnostic and treatment services pose a severe threat of adverse effects from these conditions and to the continuation of treatment.
IMPACT OF ONGOING RECESSION
The ongoing global recession continues to negatively impacted on businesses around the globe the medical device industry globally is expected to come out unscathed. Several continuous phenomena are to blame for the fact that it has so far managed to withstand the global economic crisis.
By Product
Implantable Cardioverter Defibrillator {ICD}
Transvenous ICD
External Defibrillators
In 2022, Implantable Cardioverter Defibrillator {ICD} segment is expected to dominate the defibrillator market share during the forecast period due to the development of ICD technology, the rising popularity of subcutaneous ICDs, and the dedication of players to the introduction of novel ICDs. The National Medical Products Administration of the People's Republic of China (NMPA) granted MicroPort Scientific Corporation (China) marketing authorization for their Platinum implantable cardioverter defibrillator across China in May 2022.
By Patient Type
Adults
Pediatric
In 2022, the adults segment is expected to dominate the defibrillator market growth due to The risk of cardiac arrest rises as the proportion of adults with cardiovascular disorders increases. An estimated 379,638 adults in the US experienced sudden cardiac arrest in 2022, according to data from the Sudden Cardiac Arrest Foundation. It is expected that this number will rise sharply in the next years. Also contributing to the segment's expansion are the growing number of elderly patients who are more susceptible to developing arrhythmias and people who are becoming more aware of the availability of public access defibrillators.
By End User
Hospital
Pre Hospital
Public Access Market
Alternate Care Market
Home Healthcare
.png)
Need any customization research on Defibrillator Market - Enquiry Now
In 2022, hospitals segment is expected to dominate the defibrillator market share of 79.9% during the forecast period owing to the most cardiac patients are being admitted to hospitals and because more operations are being done in hospitals. Additionally, hospitals are using both ICDs and external defibrillators more frequently to treat patients suffering from sudden cardiac arrest as well as for other purposes. As of January 2022, Boston Scientific, for instance, estimated that there were approximately 689,216 ICDs distributed worldwide.
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
North America held a significant market share growth of 42.5% in 2022 and is likely to maintain its dominance during the forecast period due to initiatives by key players, favorable rules, and modern healthcare facilities in the United States and Canada. For instance, Boston Scientific stated that in 2022, it distributed around 34,271 of its CRT-Ds product line, which includes the Resonate, Autogen, Dynagen, Incepta, and Cognis devices, globally. Out of these, 17,300 were registered in the U.S. alone indicating a high adoption rate.
Asia-Pacific is witness to expand fastest CAGR rate of 9.7% during the projected period due to the growing patient population, expanding healthcare infrastructure, and the frequency of heart illnesses. Due to the widespread use of defibrillators and supporting policies, the Japanese market is driving regional growth. In fact, Nihon Kohden, a market leader in Japan, reported sales of manual external defibrillators totaling over USD 68,400 in 2022.
The major key players are Medtronic, Stryker, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, Abbott, MicroPort Scientific Corporation, Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Ltd., BIOTRONIK SE & Co. KG, Metrax GmbH, and Others.
Medtronic, in February 2023, For the treatment of abnormal heart rhythm, Medtronic's implantable defibrillator systems, Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan, obtained the CE Mark.
Koninklijke Philips N.V., in January 2022, Koninklijke Philips N.V. acquired Cardiologs to grow its cardiac diagnostic and monitoring product offerings.
| Report Attributes | Details |
| Market Size in 2023 | US$ 7.07 Billion |
| Market Size by 2031 | US$ 13.98 Billion |
| CAGR | CAGR of 8.71% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Implantable Cardioverter Defibrillator {ICD}, Transvenous ICD, External Defibrillators) • By Patient Type (Adults, Pediatric) • By End User (Hospital, Pre Hospital, Public Access Market, Alternate Care Market, Home Healthcare) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Medtronic, Stryker, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, Abbott, MicroPort Scientific Corporation, Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Ltd., BIOTRONIK SE & Co. KG, Metrax GmbH |
| Key Drivers | • Increasing prevalence of diseases • Rising global geriatric population |
| Market Challenges | • Lack of awareness about sudden cardiac arrests in developing nations |
Ans: The Defibrillator Market is expected to grow at 8.1% CAGR from 2023 to 2030.
Ans: According to our analysis, the Defibrillator Market is anticipated to reach USD 12.8 billion By 2030.
Ans: The leading participants are F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Siemens Healthineers AG, and Others.
Ans: Factors such as the increasing elderly population and rising chronic diseases. Also, the research and development in the clinical chemistry analyszer.
Ans: Yes, you may request customization based on your company's needs.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Defibrillator Market, By Product
8.1 Implantable Cardioverter Defibrillator {ICD}
8.2 Transvenous ICD
8.3 External Defibrillators
9. Defibrillator Market, By Patient Type
9.1 Adults
9.2 Pediatric
10. Defibrillator Market, By End User
10.1 Hospital
10.2 Pre Hospital
10.3 Public Access Market
10.4 Alternate Care Market
10.5 Home Healthcare
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Defibrillator Market by country
11.2.2 North America Defibrillator Market by Product
11.2.3 North America Defibrillator Market by Patient Type
11.2.4 North America Defibrillator Market by End User
11.2.5 USA
11.2.5.1 USA Defibrillator Market by Product
11.2.5.2 USA Defibrillator Market by Patient Type
11.2.5.3 USA Defibrillator Market by End User
11.2.6 Canada
11.2.6.1 Canada Defibrillator Market by Product
11.2.6.2 Canada Defibrillator Market by Patient Type
11.2.6.3 Canada Defibrillator Market by End User
11.2.7 Mexico
11.2.7.1 Mexico Defibrillator Market by Product
11.2.7.2 Mexico Defibrillator Market by Patient Type
11.2.7.3 Mexico Defibrillator Market by End User
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Defibrillator Market by country
11.3.1.2 Eastern Europe Defibrillator Market by Product
11.3.1.3 Eastern Europe Defibrillator Market by Patient Type
11.3.1.4 Eastern Europe Defibrillator Market by End User
11.3.1.5 Poland
11.3.1.5.1 Poland Defibrillator Market by Product
11.3.1.5.2 Poland Defibrillator Market by Patient Type
11.3.1.5.3 Poland Defibrillator Market by End User
11.3.1.6 Romania
11.3.1.6.1 Romania Defibrillator Market by Product
11.3.1.6.2 Romania Defibrillator Market by Patient Type
11.3.1.6.3 Romania Defibrillator Market by End User
11.3.1.7 Turkey
11.3.1.7.1 Turkey Defibrillator Market by Product
11.3.1.7.2 Turkey Defibrillator Market by Patient Type
11.3.1.7.3 Turkey Defibrillator Market by End User
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Defibrillator Market by Product
11.3.1.8.2 Rest of Eastern Europe Defibrillator Market by Patient Type
11.3.1.8.3 Rest of Eastern Europe Defibrillator Market by End User
11.3.2 Western Europe
11.3.2.1 Western Europe Defibrillator Market by Product
11.3.2.2 Western Europe Defibrillator Market by Patient Type
11.3.2.3 Western Europe Defibrillator Market by End User
11.3.2.4 Germany
11.3.2.4.1 Germany Defibrillator Market by Product
11.3.2.4.2 Germany Defibrillator Market by Patient Type
11.3.2.4.3 Germany Defibrillator Market by End User
11.3.2.5 France
11.3.2.5.1 France Defibrillator Market by Product
11.3.2.5.2 France Defibrillator Market by Patient Type
11.3.2.5.3 France Defibrillator Market by End User
11.3.2.6 UK
11.3.2.6.1 UK Defibrillator Market by Product
11.3.2.6.2 UK Defibrillator Market by Patient Type
11.3.2.6.3 UK Defibrillator Market by End User
11.3.2.7 Italy
11.3.2.7.1 Italy Defibrillator Market by Product
11.3.2.7.2 Italy Defibrillator Market by Patient Type
11.3.2.7.3 Italy Defibrillator Market by End User
11.3.2.8 Spain
11.3.2.8.1 Spain Defibrillator Market by Product
11.3.2.8.2 Spain Defibrillator Market by Patient Type
11.3.2.8.3 Spain Defibrillator Market by End User
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Defibrillator Market by Product
11.3.2.9.2 Netherlands Defibrillator Market by Patient Type
11.3.2.9.3 Netherlands Defibrillator Market by End User
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Defibrillator Market by Product
11.3.2.10.2 Switzerland Defibrillator Market by Patient Type
11.3.2.10.3 Switzerland Defibrillator Market by End User
11.3.2.11 Austria
11.3.2.11.1 Austria Defibrillator Market by Product
11.3.2.11.2 Austria Defibrillator Market by Patient Type
11.3.2.11.3 Austria Defibrillator Market by End User
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Defibrillator Market by Product
11.3.2.12.2 Rest of Western Europe Defibrillator Market by Patient Type
11.3.2.12.3 Rest of Western Europe Defibrillator Market by End User
11.4 Asia-Pacific
11.4.1 Asia-Pacific Defibrillator Market by country
11.4.2 Asia-Pacific Defibrillator Market by Product
11.4.3 Asia-Pacific Defibrillator Market by Patient Type
11.4.4 Asia-Pacific Defibrillator Market by End User
11.4.5 China
11.4.5.1 China Defibrillator Market by Product
11.4.5.2 China Defibrillator Market by Patient Type
11.4.5.3 China Defibrillator Market by End User
11.4.6 India
11.4.6.1 India Defibrillator Market by Product
11.4.6.2 India Defibrillator Market by Patient Type
11.4.6.3 India Defibrillator Market by End User
11.4.7 Japan
11.4.7.1 Japan Defibrillator Market by Product
11.4.7.2 Japan Defibrillator Market by Patient Type
11.4.7.3 Japan Defibrillator Market by End User
11.4.8 South Korea
11.4.8.1 South Korea Defibrillator Market by Product
11.4.8.2 South Korea Defibrillator Market by Patient Type
11.4.8.3 South Korea Defibrillator Market by End User
11.4.9 Vietnam
11.4.9.1 Vietnam Defibrillator Market by Product
11.4.9.2 Vietnam Defibrillator Market by Patient Type
11.4.9.3 Vietnam Defibrillator Market by End User
11.4.10 Singapore
11.4.10.1 Singapore Defibrillator Market by Product
11.4.10.2 Singapore Defibrillator Market by Patient Type
11.4.10.3 Singapore Defibrillator Market by End User
11.4.11 Australia
11.4.11.1 Australia Defibrillator Market by Product
11.4.11.2 Australia Defibrillator Market by Patient Type
11.4.11.3 Australia Defibrillator Market by End User
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Defibrillator Market by Product
11.4.12.2 Rest of Asia-Pacific Defibrillator Market by Patient Type
11.4.12.3 Rest of Asia-Pacific Defibrillator Market by End User
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Defibrillator Market by country
11.5.1.2 Middle East Defibrillator Market by Product
11.5.1.3 Middle East Defibrillator Market by Patient Type
11.5.1.4 Middle East Defibrillator Market by End User
11.5.1.5 UAE
11.5.1.5.1 UAE Defibrillator Market by Product
11.5.1.5.2 UAE Defibrillator Market by Patient Type
11.5.1.5.3 UAE Defibrillator Market by End User
11.5.1.6 Egypt
11.5.1.6.1 Egypt Defibrillator Market by Product
11.5.1.6.2 Egypt Defibrillator Market by Patient Type
11.5.1.6.3 Egypt Defibrillator Market by End User
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Defibrillator Market by Product
11.5.1.7.2 Saudi Arabia Defibrillator Market by Patient Type
11.5.1.7.3 Saudi Arabia Defibrillator Market by End User
11.5.1.8 Qatar
11.5.1.8.1 Qatar Defibrillator Market by Product
11.5.1.8.2 Qatar Defibrillator Market by Patient Type
11.5.1.8.3 Qatar Defibrillator Market by End User
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Defibrillator Market by Product
11.5.1.9.2 Rest of Middle East Defibrillator Market by Patient Type
11.5.1.9.3 Rest of Middle East Defibrillator Market by End User
11.5.2 Africa
11.5.2.1 Africa Defibrillator Market by country
11.5.2.2 Africa Defibrillator Market by Product
11.5.2.3 Africa Defibrillator Market by Patient Type
11.5.2.4 Africa Defibrillator Market by End User
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Defibrillator Market by Product
11.5.2.5.2 Nigeria Defibrillator Market by Patient Type
11.5.2.5.3 Nigeria Defibrillator Market by End User
11.5.2.6 South Africa
11.5.2.6.1 South Africa Defibrillator Market by Product
11.5.2.6.2 South Africa Defibrillator Market by Patient Type
11.5.2.6.3 South Africa Defibrillator Market by End User
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Defibrillator Market by Product
11.5.2.7.2 Rest of Africa Defibrillator Market by Patient Type
11.5.2.7.3 Rest of Africa Defibrillator Market by End User
11.6 Latin America
11.6.1 Latin America Defibrillator Market by country
11.6.2 Latin America Defibrillator Market by Product
11.6.3 Latin America Defibrillator Market by Patient Type
11.6.4 Latin America Defibrillator Market by End User
11.6.5 Brazil
11.6.5.1 Brazil Defibrillator Market by Product
11.6.5.2 Brazil Defibrillator Market by Patient Type
11.6.5.3 Brazil Defibrillator Market by End User
11.6.6 Argentina
11.6.6.1 Argentina Defibrillator Market by Product
11.6.6.2 Argentina Defibrillator Market by Patient Type
11.6.6.3 Argentina Defibrillator Market by End User
11.6.7 Colombia
11.6.7.1 Colombia Defibrillator Market by Product
11.6.7.2 Colombia Defibrillator Market by Patient Type
11.6.7.3 Colombia Defibrillator Market by End User
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Defibrillator Market by Product
11.6.8.2 Rest of Latin America Defibrillator Market by Patient Type
11.6.8.3 Rest of Latin America Defibrillator Market by End User
12 Company Profile
12.1 Medtronic
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Stryker
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Koninklijke Philips N.V.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Asahi Kasei Corporation
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Boston Scientific Corporation
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Abbott
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 MicroPort Scientific Corporation
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Nihon Kohden Corporation
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Shenzhen Comen Medical Instruments Ltd.
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 BIOTRONIK SE & Co. KG
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 Metrax GmbH
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Products/ Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.12 Metrax GmbH
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Products/ Services Offered
12.12.4 SWOT Analysis
12.12.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. USE Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Chromatography Software Market Size was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.8 billion by 2031 and grow at a CAGR of 11.4% over the forecast period 2024-2031.
The Lab Automation Market size was estimated USD 5.74 billion in 2023 and is expected to reach USD 9.14 billion by 2031 at a CAGR of 6.19% during the forecast period of 2024-2031.
The Remote Patient Monitoring (RPM) Market Size was valued at USD 51.4 billion in 2022, and is expected to reach USD 354.49 billion by 2030, and grow at a CAGR of 27.3% over the forecast period 2023-2030.
The AI in Cancer Diagnosis market was valued at USD 118.54 billion in 2022 and is expected to reach at USD 845.78 billion by 2030 and grow at a CAGR of 27.8% over the forecast period of 2023-2030.
The Hospital Capacity Management Solutions Market Size was valued at USD 3.56 billion in 2022, and is expected to reach USD 12.68 billion by 2030 and grow at a CAGR of 17.2% over the forecast period 2023-2030.
The Hip Replacement Market Size was valued at USD 7.22 Bn in 2022 and is expected to reach USD 10.50 Bn by 2030 and grow at a CAGR of 5.1% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
